at Zacks.com (Tue, 6:00PM)
Watson Pharmaceuticals (WPI -0.25%) sues the FDA for "improperly" denying the company's shared...
Watson Pharmaceuticals (WPI -0.25%) sues the FDA for "improperly" denying the company's shared exclusivity for a generic version of Type 2 diabetes drug Actos despite the firm following the agency's directions. As a result of the FDA's decision, Watson's abbreviated new drug application (ANDA) could be delayed for up to six months.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Investor's Business Daily (Jan 22, 2015)
at Zacks.com (Jan 20, 2015)
at CNBC.com (Jan 16, 2015)
at CNBC.com (Jan 14, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs